FDA grants clearance for Endogena’s age-related macular degeneration treatment

25th October 2023 Uncategorised 0

The company will launch a clinical investigation of EA-2351 for geographic atrophy

More: FDA grants clearance for Endogena’s age-related macular degeneration treatment
Source: News